Frontiers in pharmacology · 2026
Can the two-point method based on peak and trough concentrations accurately estimate the area under the curve of polymyxin B? A Monte Carlo simulation study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Jieqiong, Zhu Jianping, Liang Gang, Yang Yi, Yu Lingyan, Zhao Yuhua, Yu Zhenwei
Аннотация
BACKGROUND: The area under the concentration‒time curve (AUC) is recognized as the therapeutic drug monitoring index of polymyxin B. The two-point method, which is based on peak and trough concentrations, is recommended for AUC estimation. However, its accuracy needs to be fully elucidated.
METHODS: A Monte Carlo simulation study was performed on published population pharmacokinetic (PPK) models. A series of plasma concentrations at steady state were simulated for each scenario. The performance of the two-point method was evaluated via mean absolute percent error (MAPE) and root mean square error (RMSE), with acceptable performance limits defined as ≤15% for the MAPE and ≤20% for the RMSE. Additionally, variations in infusion duration, body weight, and creatinine clearance were also investigated.
RESULTS: In the one-compartment model, the two-point method exhibits excellent predictive performance, characterized by both the MAPE and RMSE < 15%. For multicompartment models, prolonging the infusion duration markedly improved the accuracy of the two-point method, as demonstrated by a decrease in the average MAPE from 30.2% to 7.78% and in the average RMSE from 35.5% to 9.12% when comparing infusion durations of 0.5 h and 2 h. Body weight and creatinine clearance had limited influences on estimation accuracy in most models.
CONCLUSION: The two-point method, which is based on peak and trough concentrations, represents a strong pharmacokinetic rationale and generate a testable hypothesis for the clinical application for estimating the AUC of polymyxin B. We suggest prolonging the infusion duration to ensure estimation accuracy in different patient settings.
METHODS: A Monte Carlo simulation study was performed on published population pharmacokinetic (PPK) models. A series of plasma concentrations at steady state were simulated for each scenario. The performance of the two-point method was evaluated via mean absolute percent error (MAPE) and root mean square error (RMSE), with acceptable performance limits defined as ≤15% for the MAPE and ≤20% for the RMSE. Additionally, variations in infusion duration, body weight, and creatinine clearance were also investigated.
RESULTS: In the one-compartment model, the two-point method exhibits excellent predictive performance, characterized by both the MAPE and RMSE < 15%. For multicompartment models, prolonging the infusion duration markedly improved the accuracy of the two-point method, as demonstrated by a decrease in the average MAPE from 30.2% to 7.78% and in the average RMSE from 35.5% to 9.12% when comparing infusion durations of 0.5 h and 2 h. Body weight and creatinine clearance had limited influences on estimation accuracy in most models.
CONCLUSION: The two-point method, which is based on peak and trough concentrations, represents a strong pharmacokinetic rationale and generate a testable hypothesis for the clinical application for estimating the AUC of polymyxin B. We suggest prolonging the infusion duration to ensure estimation accuracy in different patient settings.